alpha-D-Glcp-(1->4)-[beta-D-Glcp-(1->3)]-D-Galp

Term ID

CHEBI:148472

Synonyms

(2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R)-5,6-dihydroxy-2-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
alpha-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->3)]-D-galactopyranose
beta-D-gluco-hexopyranosyl-(1->3)-[alpha-D-gluco-hexopyranosyl-(1->4)]-D-galacto-hexopyranose
Glc(b1-3)[Glc(a1-4)]Gal

Definition

A trisaccharide that is D-galactopyranose in which the hydroxy groups at positions 3 and 4 have been converted to the β-D-glucopyranosyl and α-D-glucopyranosyl derivatives, respectively.

References

glygen:G25566KR
glytoucan:G25566KR
kegg.glycan:G02074

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Glcp-(1->4)-[beta-D-Glcp-(1->3)]-D-Galp

Phenotype where environments contain alpha-D-Glcp-(1->4)-[beta-D-Glcp-(1->3)]-D-Galp

Phenotype modified by environments containing alpha-D-Glcp-(1->4)-[beta-D-Glcp-(1->3)]-D-Galp

Phenotype affecting alpha-D-Glcp-(1->4)-[beta-D-Glcp-(1->3)]-D-Galp

Human Disease Model